Repurposing of FDA-approved drugs to target MurB and MurE enzymes in <i>Mycobacterium tuberculosis</i>.

Rani, Jyoti; Silla, Yumnam; Borah, Kasmika; Ramachandran, Srinivasan; Bajpai, Urmi

Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis.

Rani, Jyoti; Silla, Yumnam; Borah, Kasmika; Ramachandran, Srinivasan; Bajpai, Urmi.

Afiliação

Rani J; Department of Biomedical Science, Acharya Narendra Dev College, University of Delhi, New Delhi, India.
Silla Y; G. N. Ramachandran Knowledge of Centre, Council of Scientific and Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi, India.
Borah K; Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, India.
Ramachandran S; Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, India.
Bajpai U; G. N. Ramachandran Knowledge of Centre, Council of Scientific and Industrial Research - Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi, India.

J Biomol Struct Dyn ; 38(9): 2521-2532, 2020 Jun.

Article em En | MEDLINE | ID: mdl-31244382

Assuntos

Mycobacterium tuberculosis; Preparações Farmacêuticas; Tuberculose; Reposicionamento de Medicamentos; Humanos; Simulação de Dinâmica Molecular; Tuberculose/tratamento farmacológico

Palavras-chave

MD simulation; Mur enzymes; Tuberculosis; docking; re-purposing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Preparações Farmacêuticas / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google